Hulting AL - Search Results

1

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.

Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M, Auriemma R, Diallo AM, Hulting AL, Ferone D, Hana V Jr, Filipponi S, Sievers C, Nogueira C, Fajardo-Montañana C, Carvalho D, Hana V, Stalla GK, Jaffrain-Réa ML, Delemer B, Colao A, Brue T, Neggers SJCMM, Zacharieva S, Chanson P, Beckers A. Petrossians P, et al. Among authors: hulting al. Endocr Relat Cancer. 2017 Oct;24(10):505-518. doi: 10.1530/ERC-17-0253. Epub 2017 Jul 21. Endocr Relat Cancer. 2017. PMID: 28733467 Free PMC article.

2

Hormonal evaluation in schizophrenic patients treated with neuroleptics.

Melkersson K, Hulting AL, Hall K. Melkersson K, et al. Among authors: hulting al. Neuro Endocrinol Lett. 1999;20(3-4):199-204. Neuro Endocrinol Lett. 1999. PMID: 11462115

3

Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses.

Melkersson K, Berinder K, Hulting AL. Melkersson K, et al. Among authors: hulting al. Neuro Endocrinol Lett. 2011;32(4):428-36. Neuro Endocrinol Lett. 2011. PMID: 21876517

4

Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.

Melkersson K, Hulting AL. Melkersson K, et al. Among authors: hulting al. Psychosomatics. 2002 Jan-Feb;43(1):67-70. doi: 10.1176/appi.psy.43.1.67. Psychosomatics. 2002. PMID: 11927762 No abstract available.

5

Serotonin receptor 2A gene polymorphisms and schizophrenia: association with family history, diagnostic subtype and height in patients.

Melkersson K, Hulting AL. Melkersson K, et al. Among authors: hulting al. Neuro Endocrinol Lett. 2009;30(3):343-51. Neuro Endocrinol Lett. 2009. PMID: 19855357

6

Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy.

Berinder K, Nyström T, Höybye C, Hall K, Hulting AL. Berinder K, et al. Among authors: hulting al. Pituitary. 2011 Sep;14(3):199-207. doi: 10.1007/s11102-010-0277-9. Pituitary. 2011. PMID: 21128120 Clinical Trial.

7

Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up.

Berinder K, Stackenäs I, Akre O, Hirschberg AL, Hulting AL. Berinder K, et al. Among authors: hulting al. Clin Endocrinol (Oxf). 2005 Oct;63(4):450-5. doi: 10.1111/j.1365-2265.2005.02364.x. Clin Endocrinol (Oxf). 2005. PMID: 16181238

8

Parity, pregnancy and neonatal outcomes in women treated for hyperprolactinaemia compared with a control group.

Berinder K, Hulting AL, Granath F, Hirschberg AL, Akre O. Berinder K, et al. Among authors: hulting al. Clin Endocrinol (Oxf). 2007 Sep;67(3):393-7. doi: 10.1111/j.1365-2265.2007.02897.x. Epub 2007 Jun 11. Clin Endocrinol (Oxf). 2007. PMID: 17561983

9

Galanin in pituitary adenomas.

Grenbäck E, Bjellerup P, Wallerman E, Lundblad L, Anggård A, Ericson K, Aman K, Landry M, Schmidt WE, Hökfelt T, Hulting AL. Grenbäck E, et al. Among authors: hulting al. Regul Pept. 2004 Feb 15;117(2):127-39. doi: 10.1016/j.regpep.2003.10.022. Regul Pept. 2004. PMID: 14700749

10

Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.

Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K, Nyström T, Bensing S. Björnsdottir S, et al. Among authors: hulting al. Clin Endocrinol (Oxf). 2015 Jul;83(1):28-35. doi: 10.1111/cen.12670. Epub 2015 Jan 12. Clin Endocrinol (Oxf). 2015. PMID: 25400085 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page